RELAPSED/REFRACTORY SCLC
Clinical trials for RELAPSED/REFRACTORY SCLC explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY SCLC trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY SCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at stubborn lung cancer
Disease control Recruiting nowThis trial is testing a new type of cell therapy for adults with small cell lung cancer that has returned or not responded to standard treatments. The therapy uses immune cells called natural killer (NK) cells, engineered to recognize and attack cancer cells through two targets a…
Matched conditions: RELAPSED/REFRACTORY SCLC
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Engineered immune cells take on tough lung cancer
Disease control Recruiting nowThis study tests a new treatment called CAR-NK cells, which are immune cells engineered to recognize and attack cancer. The trial enrolls 60 adults with small cell lung cancer that has come back or not responded to standard treatments. Participants receive the cells along with ch…
Matched conditions: RELAPSED/REFRACTORY SCLC
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC